Erika Bereczki

1.9k total citations
40 papers, 1.4k citations indexed

About

Erika Bereczki is a scholar working on Physiology, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Erika Bereczki has authored 40 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Physiology, 16 papers in Molecular Biology and 11 papers in Cellular and Molecular Neuroscience. Recurrent topics in Erika Bereczki's work include Alzheimer's disease research and treatments (17 papers), Parkinson's Disease Mechanisms and Treatments (6 papers) and Neuroscience and Neuropharmacology Research (5 papers). Erika Bereczki is often cited by papers focused on Alzheimer's disease research and treatments (17 papers), Parkinson's Disease Mechanisms and Treatments (6 papers) and Neuroscience and Neuropharmacology Research (5 papers). Erika Bereczki collaborates with scholars based in Sweden, Hungary and United Kingdom. Erika Bereczki's co-authors include Miklós Sántha, Bengt Winblad, Dag Aarsland, Clive Ballard, Paul T. Francis, Tibor Hortobágyi, Joana B. Pereira, Tamás Csont, Jin-Jing Pei and Rui M. Branca and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Brain.

In The Last Decade

Erika Bereczki

39 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Erika Bereczki Sweden 22 623 510 280 217 192 40 1.4k
Aileen M. Moloney United Kingdom 8 805 1.3× 673 1.3× 354 1.3× 126 0.6× 219 1.1× 9 1.6k
Fernando Benito Bartolomé Spain 21 551 0.9× 658 1.3× 198 0.7× 94 0.4× 366 1.9× 82 1.6k
Helena Decker Brazil 14 1.0k 1.7× 591 1.2× 538 1.9× 167 0.8× 108 0.6× 21 1.9k
Patricia Spilman United States 15 767 1.2× 695 1.4× 198 0.7× 158 0.7× 144 0.8× 26 1.5k
Tiago Gil Oliveira Portugal 16 557 0.9× 903 1.8× 212 0.8× 177 0.8× 136 0.7× 42 1.5k
Isaac G. Onyango United States 19 674 1.1× 822 1.6× 220 0.8× 101 0.5× 205 1.1× 32 1.6k
Guiqiong He China 22 680 1.1× 679 1.3× 233 0.8× 95 0.4× 66 0.3× 41 1.4k
Violette Koziel France 28 709 1.1× 911 1.8× 379 1.4× 197 0.9× 95 0.5× 50 2.0k
Feng‐Shiun Shie Taiwan 25 699 1.1× 569 1.1× 320 1.1× 95 0.4× 228 1.2× 42 1.8k
Carmela Matrone Italy 24 625 1.0× 668 1.3× 509 1.8× 91 0.4× 105 0.5× 49 1.7k

Countries citing papers authored by Erika Bereczki

Since Specialization
Citations

This map shows the geographic impact of Erika Bereczki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erika Bereczki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erika Bereczki more than expected).

Fields of papers citing papers by Erika Bereczki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erika Bereczki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erika Bereczki. The network helps show where Erika Bereczki may publish in the future.

Co-authorship network of co-authors of Erika Bereczki

This figure shows the co-authorship network connecting the top 25 collaborators of Erika Bereczki. A scholar is included among the top collaborators of Erika Bereczki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erika Bereczki. Erika Bereczki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bereczki, Erika, Francesca Mangialasche, Mariagnese Barbera, et al.. (2025). Risk reduction and precision prevention across the Alzheimer’s disease continuum: a systematic review of clinical trials combining multidomain lifestyle interventions and pharmacological or nutraceutical approaches. The Journal of Prevention of Alzheimer s Disease. 12(10). 100367–100367.
2.
Branca, Rui M., Paul T. Francis, Clive Ballard, et al.. (2024). Proteomic signatures of Alzheimer's disease and Lewy body dementias: A comparative analysis. Alzheimer s & Dementia. 21(1). e14375–e14375. 5 indexed citations
3.
Enache, Daniela, Simone Tambaro, Cristina Rosell‐Valle, et al.. (2022). Translational potential of synaptic alterations in Alzheimer’s disease patients and amyloid precursor protein knock-in mice. Brain Communications. 5(1). fcad001–fcad001. 3 indexed citations
4.
Bridi, Jéssika Cristina, Erika Bereczki, Benjamin Kottler, et al.. (2021). Presynaptic accumulation of α-synuclein causes synaptopathy and progressive neurodegeneration in Drosophila. Brain Communications. 3(2). fcab049–fcab049. 13 indexed citations
5.
Benfeitas, Rui, Sophia Schedin‐Weiss, Erika Bereczki, et al.. (2021). Insights into the changes in the proteome of Alzheimer disease elucidated by a meta-analysis. Scientific Data. 8(1). 312–312. 19 indexed citations
6.
Ioja, Enikő, Erika Bereczki, Kjell Hultenby, et al.. (2015). mTor mediates tau localization and secretion: Implication for Alzheimer's disease. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1853(7). 1646–1657. 90 indexed citations
7.
Ordóñez‐Gutiérrez, Lara, Francesca Re, Erika Bereczki, et al.. (2014). Repeated intraperitoneal injections of liposomes containing phosphatidic acid and cardiolipin reduce amyloid-β levels in APP/PS1 transgenic mice. Nanomedicine Nanotechnology Biology and Medicine. 11(2). 421–430. 72 indexed citations
8.
Wang, Shan, et al.. (2014). mTOR-mediated hyperphosphorylation of tau in the hippocampus is involved in cognitive deficits in streptozotocin-induced diabetic mice. Metabolic Brain Disease. 29(3). 729–736. 39 indexed citations
9.
Lénárt, Nikolett, Viktor Szegedi, Gábor Juhász, et al.. (2012). Increased Tau Phosphorylation and Impaired Presynaptic Function in Hypertriglyceridemic ApoB-100 Transgenic Mice. PLoS ONE. 7(9). e46007–e46007. 23 indexed citations
10.
Bereczki, Erika, Francesca Re, Massimo Masserini, Bengt Winblad, & Jin Pei. (2011). Liposomes functionalized with acidic lipids rescue Aβ-induced toxicity in murine neuroblastoma cells. Nanomedicine Nanotechnology Biology and Medicine. 7(5). 560–571. 24 indexed citations
11.
Csont, Tamás, Anikó Görbe, Erika Bereczki, et al.. (2010). Biglycan protects cardiomyocytes against hypoxia/reoxygenation injury: Role of nitric oxide. Journal of Molecular and Cellular Cardiology. 48(4). 649–652. 32 indexed citations
12.
Sallo, Ferenc B., Erika Bereczki, Tamás Csont, et al.. (2009). Bruch's membrane changes in transgenic mice overexpressing the human biglycan and apolipoprotein b-100 genes. Experimental Eye Research. 89(2). 178–186. 22 indexed citations
13.
Su, Qiaozhu, Julie Tsai, Elaine Xu, et al.. (2009). Apolipoprotein B100 acts as a molecular link between lipid-induced endoplasmic reticulum stress and hepatic insulin resistance #. Hepatology. 50(1). 77–84. 88 indexed citations
14.
Süle, Zoltán, Éva Mracskó, Erika Bereczki, et al.. (2009). Capillary injury in the ischemic brain of hyperlipidemic, apolipoprotein B-100 transgenic mice. Life Sciences. 84(25-26). 935–939. 14 indexed citations
15.
Bereczki, Erika & Miklós Sántha. (2008). The Role of Biglycan in the Heart. Connective Tissue Research. 49(3-4). 129–132. 18 indexed citations
16.
Bereczki, Erika, Miklós Sántha, Tibor Wenger, et al.. (2008). CB2 cannabinoid receptor antagonist SR144528 decreases mu-opioid receptor expression and activation in mouse brainstem: Role of CB2 receptor in pain. Neurochemistry International. 53(6-8). 309–316. 29 indexed citations
17.
18.
Bereczki, Erika, et al.. (2007). Noladin ether, a putative endocannabinoid, inhibits μ-opioid receptor activation via CB2 cannabinoid receptors. Neurochemistry International. 52(1-2). 321–328. 31 indexed citations
19.
Csont, Tamás, Erika Bereczki, Péter Bencsik, et al.. (2007). Hypercholesterolemia increases myocardial oxidative and nitrosative stress thereby leading to cardiac dysfunction in apoB-100 transgenic mice. Cardiovascular Research. 76(1). 100–109. 91 indexed citations
20.
Bereczki, Erika, Anna Juhász, Ágnes Rimanóczy, et al.. (2006). Human apoB overexpression and a high-cholesterol diet differently modify the brain APP metabolism in the transgenic mouse model of atherosclerosis. Neurochemistry International. 49(4). 393–400. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Aileen M. Moloney Breakdown of academic impact, for papers by Fernando Benito Bartolomé Breakdown of academic impact, for papers by Helena Decker Breakdown of academic impact, for papers by Patricia Spilman Breakdown of academic impact, for papers by Tiago Gil Oliveira Breakdown of academic impact, for papers by Isaac G. Onyango Breakdown of academic impact, for papers by Guiqiong He Breakdown of academic impact, for papers by Violette Koziel Breakdown of academic impact, for papers by Feng‐Shiun Shie Breakdown of academic impact, for papers by Carmela Matrone
Rankless by CCL
2026